• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Glooko, T1D Exchange ink diabetes data partnership deal

June 6, 2019 By Fink Densford

Glooko

Glooko said this week that it inked an agreement with nonprofit research organization T1D Exchange to use Glooko’s diabetes management solution to incorporate anonymized diabetes data into the TID Exchange Quality Improvement Collaborative (QIC).

Mountain View, Calif.-based Glooko said that the QIC is a data platform and learning collaborative made up of 11 U.S. diabetes centers, and that it believes the agreement “will result in one of the richest patient data sets to study T1D and drive advances in treatment and care.”

“The T1D Exchange partnership with Glooko will provide clinicians with an entirely new level of insight by giving them for the first time access to analyzed raw device data linked with EMR data. We will be able to use these comprehensive data analytics to ultimately expand outcome measures for T1D and move beyond A1c, informing our effort and mission to improve outcomes for people living with the disease,” T1D Exchange interim COO Rebecca Parkes said in a press release.

The T1D Exchange’s QIC researches all aspects of how people with T1D and their healthcare professionals measure, treat and manage diabetes, Glooko said.

“T1D Exchange offers one of the best resources available today to diabetes researchers working to make a real difference in the life of people with T1D. The team at Glooko is excited to have the privilege of enhancing the value of that resource by making it possible to securely integrate peoples’ anonymized diabetes device data into the T1D Exchange data platform, and we look forward to partnering with the team at T1D Exchange to make that happen,” Glooko CEO Russ Johannesson said in a prepared statement.

As part of the agreement, Glooko’s platform will now provide the means to transfer diabetes device data of patients treated at medical centers in the Q1C to the T1D Exchange QIC data platform as de-identified data.

Diabetes centers participating members of the QIC include theBarbara Davis Center for Diabetes/Children’s Hospital Colorado, Baylor College of Medicine/Texas Children’s Hospital, Cincinnati Children’s Hospital, C.S. Mott Children’s Hospital, U of Michigan Hospitals-Michigan Medicine, The Joslin Diabetes Center – SUNY Upstate Medical University, Lucile Packard Children’s Hospital/Stanford, Nationwide Children’s Hospital, Penn Rodebaugh Diabetes Center, Penn Medicine, University of Missouri, Kansas City/Children’s Mercy Kansas City and Wayne State University, Glooko said.

“Healthcare data are plenteous, but diversity, volume and formatting make it challenging for people with T1D and their medical teams to use it for decision-making. The partnership between Glooko and T1D Exchange will organize raw, patient-generated data and facilitate linkage with healthcare records—a novel approach in diabetes. At the level of the individual, we will make better decisions; for the population, we will understand trends and be able to track a broader range of outcomes,” Dr. Todd Alonso of the Barbara Davis Center, University of Colorado said in preapred remarks.

Yesterday, Companion Medical said that it inked a partnership deal with Glooko to integrate data from its InPen smart insulin injection pen into Glooko’s diabetes data management system and mobile application.

Filed Under: Business/Financial News, Diabetes, Patient Monitoring Tagged With: glooko

IN CASE YOU MISSED IT

  • BD files patent infringement lawsuit against Baxter over infusion pump tech
  • Tandem Diabetes Care subsidiary earns new FDA clearance for insulin infusion set
  • Glucotrack can proceed with long-term glucose monitor study in Australia
  • Dexcom promotes Jake Leach to president role
  • Roche invests $550M to make Indianapolis a CGM manufacturing hub

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS